CELESTENE CHRONODOSE 5.70 mg/ml, suspension for injection ampoule, 1 ml, CIP 3400930194775
Active ingredients: Betamethasone acetate, Betamethasone, Betamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionampoule, 1 ml, CIP 3400930194775endosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CELESTENE CHRONODOSE 5,70 mg/ml, suspension injectable
- Pharmaceutical form
- suspension injectable
- Route of administration
- endosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire
- Presentation description
- 1 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Jul 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68791304CIP73019477CIP133400930194775Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE BÉTAMÉTHASONEsuspension | 3,00 mg · une ampoule de 1 ml | SA |
| BÉTAMÉTHASONEsuspension | 2,70 mg · une ampoule de 1 ml | FT |
| BÉTAMÉTHASONEsuspension | 3,00 mg · une ampoule de 1 ml | FT |
| BÉTAMÉTHASONE (PHOSPHATE DISODIQUE DE)suspension | 3,94 mg · une ampoule de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.